With the earnings season looming, investors are scrambling to identify the best long-term stocks to buy. Hopes for a soft landing for the economy have largely faded away after the third consecutive 75-basis-point interest rate hike by the Federal Reserve. Meanwhile, other than the energy sector, recession fears have restrained forward-looking guidance for most companies.
There’s no doubt about it: XPeng (NYSE:XPEV) wants the world to know that the company just unveiled a new SUV. That’s all fine and well, but was this event enough to assuage investors’ concerns about XPeng? So far, the answer is no. The Chinese automakers’ dwindling deliveries, along with macroeconomic issues, are legitimate issues and could
Sometimes, it’s hard to know who or what to believe. Such is the case when it comes to the ongoing U.S. Securities and Exchange Commission (SEC) probe into Cassava Sciences (NASDAQ:SAVA). As the biopharmaceutical company contends with data-manipulation allegations, traders have to figure out what to do with SAVA stock. There may be evidence that the
An employee arranges Apple iPhones as customer shop at an Apple store. Mike Segar | Reuters Check out the companies making headlines in midday trading. Apple — The big technology stock shed nearly 5% following a rare downgrade by Bank of America. The bank downgraded shares of the iPhone maker to neutral and cut its
September has historically been the worst month for stocks. With the S&P 500 down 7.5% with one trading day to go, you could say September is living up to its reputation. Well, almost. The index actually did worse in April and June, falling 9% and 8.8%, respectively. For September to claim its title, the S&P
It’s been a tumultous couple of years of real estate stocks. The pandemic caused unprecedented changes in people’s daily lives and working habits. Some categories of real estate investment trusts (REITs) benefitted from these adjustments. Sub-sectors such as data centers and industrial warehouses enjoyed a surge in demand during the pandemic period. Many categories of
Economic conditions can vary widely among states. It’s difficult to get a complete picture of a given area without taking all the key factors into consideration. In the case of credit scores, knowing the average can help residents of a state see how they compare to their neighbors—and make it simpler for those considering a
Dan Ivascyn, PIMCO, at CNBC’s Delivering Alpha, Sept. 28, 2022. Scott Mlyn | CNBC The U.S. is likely headed toward a recession but there’s a chance for the downturn to be comparatively mild due to strong underlying fundamentals, according to Pimco bond expert Dan Ivascyn. In remarks echoed by other speakers Wednesday at CNBC’s Delivering
In this article AAPL KMX BBBY RAD Follow your favorite stocksCREATE FREE ACCOUNT Check out the companies making headlines before the bell: Apple (AAPL) – Apple lost 2.2% in the premarket after BofA Securities downgraded it to neutral from buy. BofA said Apple has held up relatively well in a down market, but it expects
As the market continues to absorb concerns like high inflation, rising interest rates, and a possible recession, the stock market is still far from getting back into bull market mode. With this, you may think it’s not the right time to consider micro-cap stocks to buy and hold. After all, as riskier, more volatile investments,
With stocks still in a bear market, adding dividend stocks may look very appealing right now. Even if the overall market keeps dropping, stocks with steady payouts could still produce positive returns for your portfolio. However, while there are opportunities out there for income-focused investors, there are also plenty of dividend stocks to sell if
Lauren Taylor Wolfe, center, Roy Swan, left, and Shundrawn Thomas at CNBC’s Delivering Alpha, Sept. 8, 2022. Scott Mlyn | CNBC ESG and sustainable investing generally have come under fire recently, with critics pointing to a lack of transparency and differing definitions sparking confusion around what investors are actually buying. Adding to the confusion is
A Biogen facility in Cambridge, Massachusetts. Brian Snyder | Reuters Check out the companies making headlines in midday trading. Apple — Apple shares fell 3.4% on Wednesday following a report that the company is ditching plans to boost new iPhone production. Instead of aiming to increase output by 6 million units in the second half
Even though the stock market has performed miserably lately, and throughout most of 2022, macroeconomic data shows there is reason to be hopeful equities can rebound meaningfully sooner rather than later. Moreover, unlike in April, May and June, a significant number of non-defensive stocks across numerous sectors are holding their own and even advancing on
This year, consumer stocks have been hammered as inflation lingers at 40-year highs and interest rates rise. The Dow Jones U.S. Consumer Goods Index is down 20% this year as consumers pull back on their spending. However, some consumer-focused companies have performed worse than others. Much worse. Whether it is due to poor management, failure to adapt
The U.S. Securities and Exchange Commission (SEC) and the U.S. Commodity Futures Trading Commission (CFTC) have levied more than $1.8 billion in penalties on various Wall Street firms for record-keeping failures. The SEC action targets 16 firms, with 11 of them having agreed to pay a combined $1.1 billion. The CFTC action covers 11 institutions,
Countries like the U.S. and U.K. are grappling with inflation that has risen to multi-year highs as the Ukraine war has caused energy prices to spike and food prices to rise. Angela Weiss | AFP | Getty Images Wall Street has a texting problem and the SEC is not happy. Last night the SEC announced charges
In this article LYFT AAPL OCGN THO DIS BIIB Follow your favorite stocksCREATE FREE ACCOUNT Check out the companies making headlines before the bell: Biogen (BIIB) – Biogen soared 45.6% in premarket trading after Biogen and Japanese partner Eisai said their experimental Alzheimer’s drug dramatically slowed the disease’s progression in a study, reducing cognitive and
Investors have a lot to worry about these days. Is the economy in a recession? What is happening to the labor market? And when will the stock market recover? These questions are hard to answer, but investors can strategically buy mid-cap stocks. The best mid-cap stocks will help mitigate portfolio risk and unlock gains. Mid-cap
Novavax (NASDAQ:NVAX) stock hasn’t had a great 2022, down 86% since the beginning of the year. The company focuses on products to treat infectious diseases but is definitely best known for its Covid-19 vaccine NVX-CoV2373, also known as Nuvaxovid. There are plenty of other competing vaccines in this category, and Novavax’s shots haven’t been strong sellers